BIO vs IDA · rev $2.58B vs P/E 24, rev $1.77B
BIO (BIO) versus IDACORP Inc (IDA) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
IDACORP Inc (IDA) is a utilities - regulated electric company listed on NYSE.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported IDA revenue for 2024-12-31 was $1.77B. Net income was $290.0M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. IDA currently screens at market cap $7.87B and trailing P/E 23.6.
BIO currently screens at market cap $0. IDA currently screens at market cap $7.87B and trailing P/E 23.6.
Not investment advice. Open the BIO and IDA stock pages for the full models.
Not investment advice.